Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6832)
All Articles published online
|
Publishing Process of This Article
|
Oct 14, 2014 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Aoyagi K, Kouhuji K, Kizaki J, Isobe T, Hashimoto K, Shirouzu K. Molecular targeting to treat gastric cancer. World J Gastroenterol 2014; 20(38): 13741-13755 [PMID: 25320512 DOI: 10.3748/wjg.v20.i38.13741] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v20/i38/13741.htm |
| Number | Citing Articles |
| 1 |
G. Quintero Aldana, M. Salgado, S. Candamio, J. C. Méndez, M. Jorge, M. Reboredo, L. Vázquez Tuñas, C. Romero, M. Covela, A. Fernández Montes, M. Carmona, Y. Vidal Insua, R. López. First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial. Clinical and Translational Oncology 2020; 22(4): 495 doi: 10.1007/s12094-019-02151-6
|
| 2 |
C. J. Wang, P. J. Tong, M. Y. Zhu. The combinational therapy of trastuzumab and cetuximab inhibits tumor growth in a patient-derived tumor xenograft model of gastric cancer. Clinical and Translational Oncology 2016; 18(5): 507 doi: 10.1007/s12094-015-1397-5
|
| 3 |
Elisabete Fernandes, Rui Freitas, Dylan Ferreira, Janine Soares, Rita Azevedo, Cristiana Gaiteiro, Andreia Peixoto, Sara Oliveira, Sofia Cotton, Marta Relvas-Santos, Luis Pedro Afonso, Carlos Palmeira, Maria José Oliveira, Rita Ferreira, André M. N. Silva, Lúcio Lara Santos, José Alexandre Ferreira. Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells. Cancers 2020; 12(4): 861 doi: 10.3390/cancers12040861
|
| 4 |
Marwa Matboli, Sarah El-Nakeep, Nourhan Hossam, Alaa Habieb, Ahmed E M Azazy, Ali E Ebrahim, Ziad Nagy, Omar Abdel-Rahman. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature. World Journal of Gastroenterology 2016; 22(26): 5896-5908 doi: 10.3748/wjg.v22.i26.5896
|
| 5 |
Duanrui Liu, Xiaoli Ma, Dongjie Xiao, Yanfei Jia, Yunshan Wang. Efficacy and safety of targeting VEGFR drugs in treatment for advanced or metastatic gastric cancer: a systemic review and meta-analysis. Oncotarget 2018; 9(8): 8120 doi: 10.18632/oncotarget.23429
|
| 6 |
Zhaoxiang Cheng, Shan Gao, Xiaojie Liang, Chao Lian, Jianquan Chen, Chao Fang, Mohammad Abdul Latif. Inhibiting PP2Acα Promotes the Malignant Phenotype of Gastric Cancer Cells through the ATM/METTL3 Axis. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/1015293
|
| 7 |
Jun Ji, Jiahui Chen, Anqiang Wang, Wei Zhang, Hongge Ju, Yang Liu, Leping Li. KK-LC-1 may be an effective prognostic biomarker for gastric cancer. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07974-7
|
| 8 |
Adam J. M. Wollman, Charlotte Fournier, Isabel Llorente-Garcia, Oliver Harriman, Alex L. Payne-Dwyer, Sviatlana Shashkova, Peng Zhou, Ta-Chun Liu, Djamila Ouaret, Jenny Wilding, Akihiro Kusumi, Walter Bodmer, Mark C. Leake. Critical roles for EGFR and EGFR–HER2 clusters in EGF binding of SW620 human carcinoma cells. Journal of The Royal Society Interface 2022; 19(190) doi: 10.1098/rsif.2022.0088
|
| 9 |
Hanyang Liu, Jun Song, Yan Zhou, Liang Cao, Yu Gong, Yi Wei, Haojun Yang, Liming Tang. Methylxanthine derivatives promote autophagy in gastric cancer cells targeting PTEN. Anti-Cancer Drugs 2019; 30(4): 347 doi: 10.1097/CAD.0000000000000724
|
| 10 |
Fengbin Zhang, Xiaoyan Liu, Bingjie Huo, Bing Li, Ruixing Zhang. Mechanism Analysis of Coix Seed in Gastric Cancer Treatment Based on Biological Network Modules. Natural Product Communications 2020; 15(5): 1934578X2092752 doi: 10.1177/1934578X20927521
|
| 11 |
Xuefen Lei, Feng Wang, Yang Ke, Dong Wei, Hou Gu, Zhixian Zhang, Lifeng Jiang, Li Lv, Jie Lin, Lin Wang. The role of antiangiogenic agents in the treatment of gastric cancer. Medicine 2017; 96(10): e6301 doi: 10.1097/MD.0000000000006301
|
| 12 |
Mayu Fujimoto, Hiroaki Kito, Junko Kajikuri, Susumu Ohya. Transcriptional repression of human epidermal growth factor receptor 2 by ClC‐3 Cl−/H+ transporter inhibition in human breast cancer cells. Cancer Science 2018; 109(9): 2781 doi: 10.1111/cas.13715
|
| 13 |
Y. Lv, L. Song, L. Chang, Y. Liu, X. Zhang, Q. Li, X. Zhou, W. Liu. Inhibitory effects of bevacizumab monoclonal antibodies in combination with chemotherapy in different time sequences on a human gastric carcinoma cell line. Irish Journal of Medical Science (1971 -) 2017; 186(2): 275 doi: 10.1007/s11845-016-1471-1
|
| 14 |
YAN-LING WU, LI-JIE XIA, JIN-YAO LI, FU-CHUN ZHANG. CecropinXJ inhibits the proliferation of human gastric cancer BGC823 cells and induces cell death in vitro and in vivo. International Journal of Oncology 2015; 46(5): 2181 doi: 10.3892/ijo.2015.2933
|
| 15 |
Ilkka Liikanen, Siri Tähtinen, Kilian Guse, Theresia Gutmann, Paula Savola, Minna Oksanen, Anna Kanerva, Akseli Hemminki. Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer. Molecular Cancer Therapeutics 2016; 15(9): 2259 doi: 10.1158/1535-7163.MCT-15-0819
|
| 16 |
Lu Han, Liufang Xiong, Cong Wang, Yan Shi, Qi Song, Gang Sun. MicroRNA-128 contributes to the progression of gastric carcinoma through GAREM-mediated MAPK signaling activation. Biochemical and Biophysical Research Communications 2018; 504(1): 295 doi: 10.1016/j.bbrc.2018.08.177
|
| 17 |
Guangzhong Xu, Kai Li, Nengwei Zhang, Bin Zhu, Guosheng Feng. Screening Driving Transcription Factors in the Processing of Gastric Cancer. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/8431480
|
| 18 |
Fengbin Zhang, Wenjuan Xu, Jun Liu, Xiaoyan Liu, Bingjie Huo, Bing Li, Zhong Wang, Andre van Wijnen. Optimizing miRNA-module diagnostic biomarkers of gastric carcinoma via integrated network analysis. PLOS ONE 2018; 13(6): e0198445 doi: 10.1371/journal.pone.0198445
|
| 19 |
Mihoko Saito-Adachi, Natsuko Hama, Yasushi Totoki, Hiromi Nakamura, Yasuhito Arai, Fumie Hosoda, Hirofumi Rokutan, Shinichi Yachida, Mamoru Kato, Akihiko Fukagawa, Tatsuhiro Shibata. Oncogenic structural aberration landscape in gastric cancer genomes. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-39263-1
|
| 20 |
Xiaojing Deng, Hailun Zheng, Dapeng Li, Yongju Xue, Qizhi Wang, Shanjun Yan, Yu Zhu, Min Deng. MicroRNA-34a regulates proliferation and apoptosis of gastric cancer cells by targeting silent information regulator 1. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.5920
|
| 21 |
Yue Cao, Peng Xu, Yangling Shen, Wei Wu, Min Chen, Fei Wang, Yuandong Zhu, Feng Yan, Weiying Gu, Yan Lin. Exosomes and cancer immunotherapy: A review of recent cancer research. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1118101
|
| 22 |
Adriana Carino, Luigina Graziosi, Claudio D’Amore, Sabrina Cipriani, Silvia Marchianò, Elisabetta Marino, Angela Zampella, Mario Rende, Paolo Mosci, Eleonora Distrutti, Annibale Donini, Stefano Fiorucci. The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines. Oncotarget 2016; 7(38): 61021 doi: 10.18632/oncotarget.10477
|